STOCK TITAN

Freightos (CRGO) CEO trims 1,524 shares in tax-related sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Freightos Ltd CEO and CFO Pablo Pinillos Manrique de Lara reported an open-market sale of 1,524 Ordinary Shares at $1.31 per share. A footnote explains this sale was made on his behalf to cover tax liability arising from the vesting of restricted share units (RSUs). Following the sale, he directly holds 32,661 Ordinary Shares and retains stock options over additional Ordinary Shares at exercise prices of $15.00, $10.00, and $5.00 per share, each expiring in 2033, as part of his ongoing equity compensation.

Positive

  • None.

Negative

  • None.
Insider Pinillos Manrique de Lara Pablo
Role CEO and CFO
Sold 1,524 shs ($2K)
Type Security Shares Price Value
Sale Ordinary Shares 1,524 $1.31 $2K
holding Stock Option (right to buy) -- -- --
holding Stock Option (right to buy) -- -- --
holding Stock Option (right to buy) -- -- --
holding Ordinary Shares -- -- --
holding Ordinary Shares -- -- --
holding Ordinary Shares -- -- --
holding Ordinary Shares -- -- --
Holdings After Transaction: Ordinary Shares — 32,661 shares (Direct, null); Stock Option (right to buy) — 33,333 shares (Direct, null)
Footnotes (1)
  1. The transaction reported in this row consists of a sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person. The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 40,000 RSUs originally granted by the Issuer to the Reporting Person that began vesting on April 1, 2025. 33.33% of such RSUs vested on April 1, 2026 (the one-year anniversary of the vesting commencement date), and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter), such that all such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) will be fully vested by the three-year anniversary of the vesting commencement date (April 1, 2028). There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. The ordinary shares reported in this row consist of shares underlying RSUs that were granted by the Issuer to, and began vesting for, the Reporting Person on April 1, 2026 and that vest and settle for underlying ordinary shares based on the following schedule: 33.33% of the subject RSUs will vest upon the one-year anniversary of the grant date (April 1, 2027), and the remainder of the RSUs will vest in eight equal installments at the conclusion of each of the following eight quarters (8.33% per quarter), such that the RSUs will be fully vested by the three-year anniversary of the vesting commencement date (April 1, 2029). The ordinary shares reported in this row consist of shares underlying RSUs granted by the Issuer to the Reporting Person that began vesting for the Reporting Person on April 1, 2025 and that vest and settle for underlying ordinary shares, in their entirety, on December 31, 2028. The ordinary shares reported in this row consist of shares underlying RSUs granted by the Issuer to the Reporting Person that began vesting for the Reporting Person on April 1, 2025 and that vest and settle for underlying ordinary shares, in their entirety, on December 31, 2027.
Shares sold 1,524 shares Ordinary Shares sold on July 2, 2026
Sale price $1.31 per share Price for 1,524 Ordinary Shares sold
Shares held after sale 32,661 shares Direct Ordinary Share holdings following transaction
Stock option strike price $15.00 per share Option over 33,334 underlying Ordinary Shares, expiring March 16, 2033
Stock option strike price $10.00 per share Option over 33,333 underlying Ordinary Shares, expiring March 16, 2033
Stock option strike price $5.00 per share Option over 33,333 underlying Ordinary Shares, expiring March 16, 2033
restricted share units ("RSUs") financial
"sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs")"
Stock Option (right to buy) financial
"security_title: "Stock Option (right to buy)""
vesting commencement date financial
"began vesting on April 1, 2025. 33.33% of such RSUs vested on April 1, 2026 (the one-year anniversary of the vesting commencement date)"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
tax liability financial
"sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Freightos (CRGO) report for its CEO and CFO?

Freightos reported that CEO and CFO Pablo Pinillos Manrique de Lara sold 1,524 Ordinary Shares. The shares were sold at $1.31 each to cover tax liabilities from vesting RSUs, according to the filing’s explanatory footnote.

At what price were the Freightos (CRGO) shares sold in this Form 4?

The reported sale of Freightos Ordinary Shares was executed at $1.31 per share. This sale covered tax obligations triggered by the vesting of restricted share units previously granted to the reporting executive.

How many Freightos (CRGO) shares does the reporting person hold after the transaction?

After the tax-related sale, the reporting person directly holds 32,661 Ordinary Shares. This figure reflects his remaining equity position excluding additional unexercised stock options and unvested RSUs described in the filing footnotes.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Pinillos Manrique de Lara Pablo

(Last)(First)(Middle)
C/O FREIGHTOS LIMITED, PLANTA 10, AVDA.
DIAGONAL, 211

(Street)
BARCELONA08018

(City)(State)(Zip)

SPAIN

(Country)
2. Issuer Name and Ticker or Trading Symbol
Freightos Ltd [ CRGO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
CEO and CFO
2a. Foreign Trading Symbol
[N/A]
3. Date of Earliest Transaction (Month/Day/Year)
07/02/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares07/02/2026S(1)1,524D$1.3132,661(2)D
Ordinary Shares(3)24,102D
Ordinary Shares(3)40,000(4)D
Ordinary Shares(3)37,500(5)D
Ordinary Shares(3)37,500(6)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)(3)$503/16/202703/16/2033Ordinary Shares33,33333,333D
Stock Option (right to buy)(3)$1003/16/202703/16/2033Ordinary Shares33,33333,333D
Stock Option (right to buy)(3)$1503/16/202703/16/2033Ordinary Shares33,33433,334D
Explanation of Responses:
1. The transaction reported in this row consists of a sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.
2. The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 40,000 RSUs originally granted by the Issuer to the Reporting Person that began vesting on April 1, 2025. 33.33% of such RSUs vested on April 1, 2026 (the one-year anniversary of the vesting commencement date), and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter), such that all such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) will be fully vested by the three-year anniversary of the vesting commencement date (April 1, 2028).
3. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
4. The ordinary shares reported in this row consist of shares underlying RSUs that were granted by the Issuer to, and began vesting for, the Reporting Person on April 1, 2026 and that vest and settle for underlying ordinary shares based on the following schedule: 33.33% of the subject RSUs will vest upon the one-year anniversary of the grant date (April 1, 2027), and the remainder of the RSUs will vest in eight equal installments at the conclusion of each of the following eight quarters (8.33% per quarter), such that the RSUs will be fully vested by the three-year anniversary of the vesting commencement date (April 1, 2029).
5. The ordinary shares reported in this row consist of shares underlying RSUs granted by the Issuer to the Reporting Person that began vesting for the Reporting Person on April 1, 2025 and that vest and settle for underlying ordinary shares, in their entirety, on December 31, 2028.
6. The ordinary shares reported in this row consist of shares underlying RSUs granted by the Issuer to the Reporting Person that began vesting for the Reporting Person on April 1, 2025 and that vest and settle for underlying ordinary shares, in their entirety, on December 31, 2027.
Remarks:
Exhibit 24.1 - Power of Attorney.
/s/ Max Sitnick, Attorney-in-fact07/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)